Announcing the Bone Marrow Failure Region of Interest test

Assesses 86 genes related to hereditary bone marrow disease

August 22, 2016

Claritas Genomics has launched the Bone Marrow Failure Region of Interest test, an exome-based test that assesses 86 genes related to known causes of hereditary bone marrow failure. Developed in collaboration with experts in hematology at Boston Children's Hospital, this assay's first results are issued at 4 weeks, providing critical information to providers and patients for treatment and management decisions. 

About Claritas

Claritas Genomics serves children affected with complex genetic disorders by providing timely and accurate results, resolving families’ long search for answers. By combining clinical expertise of the world’s best pediatric specialists with innovative platform solutions, Claritas is working to improve patient care and enable new discoveries. We are committed to the highest quality and accessibility of information and our interpretive services and unique approach to reporting set the standard for reliably and clearly communicating genetic information.

Now is the time to integrate genomics into clinical practice to inform, guide and improve medical treatment for kids around the world.